Amarin Corp Plc\uk Sample Contracts

EXHIBIT A
Amarin Corp Plc\uk • April 24th, 2003 • Pharmaceutical preparations • New York
AutoNDA by SimpleDocs
EXHIBIT B
Registration Rights Agreement • April 24th, 2003 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
AMENDED AND RESTATED ASSET PURCHASE AGREEMENT
Asset Purchase Agreement • April 24th, 2003 • Amarin Corp Plc\uk • Pharmaceutical preparations • Delaware
DATED 2003
Warrant Agreement • April 24th, 2003 • Amarin Corp Plc\uk • Pharmaceutical preparations • England
EXHIBIT 2.6 REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • April 24th, 2003 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
AND CITIBANK, N.A., As Depositary AND
Deposit Agreement • November 28th, 2007 • Amarin Corp Plc\uk • Pharmaceutical preparations
INTRODUCTION
Execution Copy • April 24th, 2003 • Amarin Corp Plc\uk • Pharmaceutical preparations • England
CONFIDENTIAL Amarin Corporation plc
Amarin Corp Plc\uk • December 17th, 2007 • Pharmaceutical preparations • New York
DEBT SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • December 17th, 2007 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of December 4, 2007, between Amarin Corporation plc, a corporation formed under the laws of England and Wales (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

AMENDMENT NO. 1 TO
Registration Rights Agreement • April 24th, 2003 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
CORSICANTO II DESIGNATED ACTIVITY COMPANY, as Issuer AMARIN CORPORATION PLC, as Guarantor AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee Indenture Dated as of January 25, 2017 3.50% Exchangeable Senior Notes due 2047
Indenture • January 25th, 2017 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York

INDENTURE, dated as of January 25, 2017 between Corsicanto II Designated Activity Company, a designated activity company incorporated under the laws of Ireland, and having its principal office at Arthur Cox Building, Earlsfort Terrace, Dublin 2, Ireland, D02 CK83, Ireland, as Issuer (the “Issuer”), Amarin Corporation plc, a company incorporated under the laws of England and Wales, and having its principal office at 2 Pembroke House, Upper Pembroke Street 28-32, Dublin 2, Ireland, as Guarantor (the “Guarantor”) and Wilmington Trust, National Association, a national banking association, as Trustee (the “Trustee”).

AMENDED AND RESTATED DEPOSIT AGREEMENT by and among AMARIN CORPORATION PLC AND CITIBANK, N.A., as Depositary, AND THE HOLDERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY SHARES ISSUED HEREUNDER Dated as of November 4, 2011
Deposit Agreement • February 29th, 2012 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York

AMENDED AND RESTATED DEPOSIT AGREEMENT, dated as of November 4, 2011, by and among (i) Amarin Corporation plc, a company organized under the laws of England and Wales, and its successors (the “Company”), (ii) CITIBANK, N.A., a national banking association organized under the laws of the United States of America acting in its capacity as depositary, and any successor depositary hereunder (the “Depositary”), and (iii) all Holders and Beneficial Owners of American Depositary Shares issued hereunder (all such capitalized terms as hereinafter defined).

Contract
Amarin Corp Plc\uk • December 23rd, 2011 • Pharmaceutical preparations • Connecticut

On behalf of Amarin Corporation plc (the “Company”), I am pleased to confirm the terms of your continued employment with the Company, effective January 1, 2012. The purpose of this letter agreement is to set forth those terms of employment. This letter agreement (the “Agreement”) fully supersedes any prior agreements, understanding or arrangements, whether oral or written, implied or express, with respect to the terms and conditions of your employment with the Company including, without limitation, any offer letter, employment agreement or other agreement or understanding relating to compensation, benefits, severance pay or other terms or conditions of employment (collectively, the “Prior Agreements”), provided any agreement you have with the Company and/or any of its subsidiaries or affiliates related to confidentiality/nondisclosure, assignment of inventions and patents, any stock option agreement entered into by you in connection an equity award issued to you by the Company or its s

AMARIN CORPORATION PLC
Award Agreement • July 9th, 2010 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
Amarin Corporation plc 22,222,223 American Depositary Shares Representing 22,222,223 Ordinary Shares (Par Value £0.50 Per Share) UNDERWRITING AGREEMENT
Underwriting Agreement • July 24th, 2019 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York

The ADSs are issued pursuant to an Amended and Restated Deposit Agreement dated as of November 4, 2011 (as so amended and supplemented, the “Deposit Agreement”) by and among the Company, Citibank, N.A., as Depositary (the “Depositary”) and all holders and beneficial owners of ADSs issued thereunder.

VARIATION AGREEMENT re: Amended and Restated Assets Purchase Agreement dated 29 September, 1999
Variation Agreement • April 24th, 2003 • Amarin Corp Plc\uk • Pharmaceutical preparations
AutoNDA by SimpleDocs
Belvedere Place BASIC LEASE INFORMATION
Belvedere Place • May 9th, 2002 • Amarin Corp Plc\uk • Pharmaceutical preparations • California
CORSICANTO LIMITED, as Issuer AMARIN CORPORATION PLC, as Guarantor AND WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee Indenture Dated as of January 9, 2012 3.50% Exchangeable Senior Notes due 2032
Amarin Corp Plc\uk • January 10th, 2012 • Pharmaceutical preparations • New York

INDENTURE, dated as of January 9, 2012 between Corsicanto Limited, a private limited company incorporated under the laws of Ireland, and having its principal office at Arthur Cox Building, Earlsfort Terrace, Dublin 2, Ireland, as Issuer (the “Issuer”), Amarin Corporation plc, a company incorporated under the laws of England and Wales, and having its principal office at 2 Pembroke House, Upper Pembroke Street 28-32, Dublin 2, Ireland, as Guarantor (the “Guarantor”) and Wells Fargo Bank, National Association, a national banking association, as Trustee (the “Trustee”).

May 26, 2022 Mr. Thomas Reilly Dear Tom:
Amarin Corp Plc\uk • August 3rd, 2022 • Pharmaceutical preparations • New Jersey

On behalf of Amarin Corporation plc (the “Company”), I am pleased to confirm our offer to employ you as Senior Vice President, Chief Financial Officer. The initial terms and conditions of your employment, should you accept this offer, are set forth below in this letter agreement (the “Agreement”),

PREFERRED SHARE DEPOSIT AGREEMENT by and among AMARIN CORPORATION PLC AND CITIBANK, N.A., as Depositary, AND THE HOLDERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY SHARES ISSUED HEREUNDER Dated as of March 30, 2015
Preferred Share Deposit Agreement • March 30th, 2015 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York

PREFERRED SHARE DEPOSIT AGREEMENT, dated as of March 30, 2015, by and among (i) Amarin Corporation plc, a company organized under the laws of England and Wales, and its successors (the “Company”), (ii) CITIBANK, N.A., a national banking association organized under the laws of the United States of America acting in its capacity as depositary, and any successor depositary hereunder (the “Depositary”), and (iii) all Holders and Beneficial Owners of American Depositary Shares issued hereunder (all such capitalized terms as hereinafter defined).

AMARIN CORPORATION PLC (a non-qualified stock option award)
Award Agreement • March 16th, 2012 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York

This AWARD AGREEMENT (the “Award Agreement”) is entered into and made effective as of March 1, 2012 between Amarin Corporation plc (the “Company”), and Steven B. Ketchum of 49 Canoe Brook Lane, Far Hills, NJ 07931 (“Optionee”), which is intended to operate as an “employees’ share scheme” within Section 1166 of the UK Companies Act 2006. This Option is not being granted under the Amarin Corporation plc 2011 Stock Incentive Plan (the “Plan”). However, capitalized terms used and not defined herein shall have the meanings set forth in the Plan. This Option is not intended to qualify as an “incentive stock option” as defined in Section 422(b) of the Internal Revenue Code of 1986, as amended from time to time (the “Code”). This Option is granted on the terms set out in this Award Agreement.

JOINT FILING AGREEMENT
Joint Filing Agreement • April 28th, 2011 • Amarin Corp Plc\uk • Pharmaceutical preparations

The undersigned hereby agree that the Statement on this Schedule 13D, dated April 28, 2011 (the “Schedule 13D”), with respect to the Ordinary Shares, 50 pence par value per share, of Amarin Corporation plc is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to this Schedule 13D. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13D, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

Dated the 12th day of April 2021 BETWEEN:
Agreement • April 29th, 2021 • Amarin Corp Plc\uk • Pharmaceutical preparations

Amarin Switzerland GmbH, Grafenauweg 8, 6300 Zug (hereinafter the ‘Company’ which expression will where the context so permits or requires include its subsidiaries and associated companies), of the one part

Dated February 23, 2009 SUPPLY AGREEMENT BETWEEN AND
Supply Agreement • December 4th, 2009 • Amarin Corp Plc\uk • Pharmaceutical preparations
Office Service Agreement Agreement Date (dd/mm/yy): 21 / 10 / 2021 Reference No.: 12678344 Business Centre Address: Client Address (Not a Business Centre Address): Regus Solna Frösunda Port Company Name: Amarin Switzerland GmbH Sweden filial Gustav...
Office Service Agreement • March 1st, 2022 • Amarin Corp Plc\uk • Pharmaceutical preparations

We are IWG Management Sweden AB , referred to in the terms and conditions as “We”, “Us”, “Our”. The Company Name listed above will be referred to in the terms and conditions as “You”, “Your”. This Agreement incorporates Our terms of business set out on attached Terms and Conditions, attached House Rules and Service Price Guide (where available), which You confirm You have read and understood. We both agree to comply with those terms and our obligations as set out in them. This agreement is binding from the agreement date and may not be terminated once it is made, except in accordance with its terms. Note that the Agreement does not come to an end automatically. See “Automatic Renewal” section of Your terms and conditions for the notice terms if You wish to end your agreement.

April 28, 2021 Joseph T. Kennedy Re:Transitional Services and Separation Agreement Dear Joe:
Amarin Corp Plc\uk • April 29th, 2021 • Pharmaceutical preparations • California

This letter confirms our agreement regarding your planned retirement and in connection therewith your resignation as EVP, General Counsel and Strategic Initiatives and Secretary of Amarin Corporation plc (the “Company”) and related positions in affiliated companies. The Board of Directors of the Company (the “Board”) appreciates your substantial contributions to the Company and would like to make this transition as seamless as possible.

AMENDMENT AND WAIVER AGREEMENT
And Waiver Agreement • December 4th, 2009 • Amarin Corp Plc\uk • Pharmaceutical preparations

Certain portions of this Exhibit have been omitted pursuant to a request for “Confidential Treatment” under Rule 24b-2 of the Securities and Exchange Commission. Such portions have been redacted and bracketed in the request and appear as [*] in the text of this Exhibit. The omitted confidential information has been filed with the Securities and Exchange Commission.

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 5th, 2007 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
AMARIN CORPORATION PLC 7 CURZON STREET LONDON W1J 5HG
Supplemental Letter Agreement • November 28th, 2007 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York

Reference is made to (i) the Deposit Agreement, dated as of March 29, 1993, as amended by Amendment No. 1 to Deposit Agreement, dated as of October 8, 1998, and as further amended by Amendment No. 2 to Deposit Agreement, dated as of September 25, 2002 (the Deposit Agreement as amended by Amendment No. 1 to Deposit Agreement and Amendment No. 2 to Deposit Agreement, the "Deposit Agreement"), by and among Amarin Corporation plc (formerly known as "Ethical Holdings plc"), a corporation organized and existing under the laws of England and Wales (the "Company"), Citibank, N.A., as Depositary (the "Depositary"), and all Holders from time to time of American Depositary Receipts ("ADRs") evidencing American Depositary Shares ("ADSs") issued thereunder and (ii) the letter agreement, dated as of March 29, 2006 (the "Letter Agreement"), between the Company and the Depositary relating to the issuance of Restricted ADSs (as defined in the Letter Agreement). Capitalized terms used but not defined he

Time is Money Join Law Insider Premium to draft better contracts faster.